*|MC:SUBJECT|*
BioRN News January 2024
View this email in your browser
January brings you outstanding research news and the BioRN Annual Conference!

Dear *|FNAME|* *|LNAME|*,
 
The first newsletter of the new year provides you with plenty of reading material, because a lot has happened in the BioRN network! 

We have a new colleague in Communications: Nicole Hecht joined the team in December 2023 and is strengthening the Events and PR department - we are delighted! 

With fresh ideas, we are starting another year full of exciting and enriching events for the life science community:
Right after the end of the holidays, we had a premiere with our first M2M - Member to Member special edition "people shaping the life science region" and an entertaining and exciting interview between Julia Schaft and Oliver Stegle, EMBL & DKFZ. Find the recording on our website

The first BioRN HR-Breakfast took place on 18 January and brought together HR-experts and -managers in an informal round table. All participants agreed on the added value of exchanging views on HR-relevant topics and the opportunity to tackle the known challenges in recruiting together as well as supporting each other. The HR Breakfast will therefore take place on a regular basis. The BioRN HR community is set to grow! If you are interested in attending the next meeting, please contact Stephanie Füller.

Tonight, Jens Puschhof will kick off the BioRN Lounge event series: We look forward to his impulse on the topic: The Microbiome in Cancer and beyond
Once a month on Tuesday evenings at 7pm, we invite BioRN members to a get-together with pizza and cool drinks and an exciting keynote speech. The next BioRN Lounge on February 27th will be  hosting a speaker from Promega GmbH who will introduce us to the technology „Lumit® Immunoassays for Research“. 

On 6 February, we welcome ValueData for an interview as part of the M2M - Member to Member series. The company uses machine learning and deep learning of driven systems to integrate intelligence into customers´products and solutions. With the help of the complete and in-depth analyses of microscopic images, ValueDatas´ Medical Brick would not only like to accelerate the diagnostic process, but also to support drug screening and drug discovery.

Last not least we want to give you a SAVE THE DATE with much anticipation:
BioRN Annual Conference 2024,
OCTOBER 9, 2024 ,
Heidelberg Congress Center (HCC)

We are in the process of developing the programme for the conference together with the BioRN Scientific Advisory Board and planning the exhibition space for a successful trade fair appearance by exhibiting companies and institutions. Please contact the BioRN Comms Team (Stephanie Füller, Nicole Hecht)  for sponsoring and exhibition packages.

Enjoy more  news from our network and mark your calendar for the upcoming events!
Kind regards,

Stephanie Füller 
PR Manager
BioRN Life Science Cluster Rhine-Neckar

 
LinkedIn
Twitter
Website
01 | Research Highlights & News
02 | New Members
03 | Events Spotlight
04 | Event Calendar & Discounts
05 | Open Positions
01 | Research Highlights & News

AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union [more]

Affimed announces positive data for AFM24 in combination with the PD-L1 checkpoint inhibitor Atezolizumab in heavily pre-treated EGFR-wildtype non-small cell lung cancer patients [more]

Arbeitskreis der BioRegionen: Innovationspreis 2024 der BioRegionen in Deutschland [more]

BIO Deutschland: Biotech industry: financing stable - trend reversal on the horizon [more]

BioLabs and Promega announce collaboration to support young biotech companies  [more]

Boehringer Ingelheim receives EU approval for SENVELGO®: the first oral solution for diabetes mellitus in cats [more]

DKFZ: 
  • Indicator for liver health status identified [more]
  • New findings and therapeutic approaches for sarcomas [more]
  • AI-based support system for skin cancer diagnostics explains its decisions [more]
  • Reprogrammed fat cells support tumor growth [more]
  • ERC Starting Grant for DKFZ researcher Angelika Feldmann [more]
  • Intestinal stem cells drive age-related inflammation [more]
EMBL: 
  • Ancient ‘relaxant-inflammatory’ response gets sponges moving [more]
  • Unveiling the vulnerabilities of pulmonary neuroendocrine tumours [more]
  • RNA to rule them all [more]
Heidelberg University:
  • Award for Flood Monitoring by App [more]
  • Dissertation with great relevance for environmental research: Award for Dr. Lisa Gölz [more]
  • Greenhouse gas calculator for hospitals - made in Heidelberg and Freiburg [more]
  • The use of artificial intelligence provides better health care for patiens with heart failure [more]
Heidelberg University and KIT: Cave Dripstones as a climate archive  [more]

Heidelberg University Hospital (UKHD): Systemic sclerosis: CAR-T cell therapy alleviates life-threatening lung damage in young woman [more]

Hopp Children's Cancer Center Heidelberg:
  • Hopp Children's Cancer Center Heidelberg launches development cooperation to provide children worldwide with modern cancer diagnostics [more]
  • Brain tumors in children: Cancer cells become less aggressive as they migrate within the tumor [more]
Hummingbird Diagnostics Announces Initiation of Patient Recruitment for Clinical Study Evaluating miLungDx as a Novel Diagnostic Test for Early-stage Lung Cancer [more]

Landesregierung BaWü: Landespreis 2024: Wir suchen die Besten!  [more]

The Federal Agency for Disruptive Innovation, SPRIND, calls for revolutionary ideas in the battle against Antimicrobial Resistance [more]

Universitätsmedizin Mannheim (UMM):
  • ERC Proof of Concept Grant für Prof. Dr. Simon Wiegert [more]
  • Omega-6 fatty acids and cardiovascular diseases - New cause of side effects discovered [more]
Pirocco Foundation invests into WMT AG [more]

02 | New Members

Valency Communication was founded as a pure-play senior advisory firm to life science companies. Valency Communications strives to support the European biotechnology ecosystem. Valency applies a unique blend of expertise in science, life science journalism, IR & Corporate Communications to advise biopharma leadership teams of different shapes and sizes. They believe, while strategic communications can’t fix a piece of broken science, it will otherwise touch almost every aspect of the successful development of a biopharmaceutical company. Companies that  communicate well and attract communities that support them, will end up on a more attractive and faster trajectory from seed round to IPO, from preclinical trial to market approval, from three scientists and a rat in a lab to “Best Places to Work”. Valency enables companies to create and execute tailored communication strategies with the same level of professionalism, creativity, and  rigor they show in all other areas of their business.

Skylabs Development & Construction GmbH, headquartered in  Heidelberg, acts as project developer and asset manager for the  Max-Jarecki-Foundation. Their collective experience, as well as their present and future goals are focused around the development of office  and laboratory real estate. Since 2009, in cooperation with numerous local, regional, national and  international partners, Skylabs has been planning and developing sites in  the up-and-coming Bahnstadt district of Heidelberg. They build, market,  maintain, rent out and hold the properties in their portfolio.

03 | Events Spotlight

04 | Event Calendar & Discounts

BioRN Lounge with Jens Puschhof (DKFZ)
Topic: „The Microbiome in Cancer and beyond”
January 30, 2024 - Heidelberg, Germany >>

 
EACR-EMBO Commercialising Your Research: What's Involved?
January 30, 2024 - Online >>
 
Venture Capital Meet & Greet with Cornelius Baral of MBG BW
February 08, 2024 - Online >>
 
Online seminar "Valuation of Academic Spin-outs in the Life Sciences"
February 15, 2024 - Online >>
 
BIOTECHGATE DIGITAL PARTNERING - Virtual business development & licensing event
February 26 - March 01, 2024 - Online
Free Premium Access for BioRN Members.  >>

 
BioRN Lounge with Promega GmbH  
February 27, 2024 - Heidelberg, Germany (Registration opens soon) >>
 
Connecting the global Biopharma community to elevate life science partnerships
March,18-20 2024 - Barcelona, Spain
10 % discount for BioRN Members. >>

 
DBT - Deutsche Biotechnologietage 2024
April 16-17, 2024 - Berlin, Germany  >>
 
CONTACT 2024 - Life Science Job Fair
April 17, 2024 - Heidelberg, DKFZ   >>
 
BioVaria - Europe’s leading showcasing event for life-science technologies
April 29-30, 2024 - Munich, Germany
The application deadline for start-ups is February 15, 2024  >>

 
Knowledge for Growth
May 15-16, 2024 - Antwerp, Belgium
BioRN Members receive 15% off prices!  >>

 
Curious2024 – Future Insight Conference
July 10-11, 2024 - Mainz, Germany & Online
Book your Curious2024 tickets now. BioRN Members receive 15% off prices!  >>
Call for Abstracts: 
Take the chance to receive a short talk, poster presentation or a booth at the start-up fair - the deadline is 31.03.2024

 
BioRN Annual Conference 2024
October 9, 2024 - Heidelberg Congress Center (HCC) Heidelberg, Germany 
All information referring exhibition and sponsoring will be soon availabe on our website.


 

05 | Open Positions


BioThrust:
  • (Junior) Product Developer – Bioreactor Main components (m/f/d)  [more]
  • Electronic Tech Integrator (m/f/d) [more]
  • Working Student Product Developer (m/f/d)  [more]
  • Senior product Developer (m/f/d)  [more]
mfd Diagnostics GmbH:
  • Biologielaborant / MTA / BTA / Biologe / Biomediziner (w/m/d)  [more]
  • Vertriebsmitarbeiter/Außendienstmitarbeiter im Bereich der biomedizinischen Forschung (w/m/d) [more]
PROGEN: Praktikant / Werkstudent Life Sciences – Marketing & Sales (m/w/d)  [more]
Tweet Tweet
Forward Forward
Share Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Stephanie Füller

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*